Annual SGA
$68.90 M
+$22.36 M+48.05%
December 31, 2024
Summary
- As of March 10, 2025, XENE annual SGA is $68.90 million, with the most recent change of +$22.36 million (+48.05%) on December 31, 2024.
- During the last 3 years, XENE annual SGA has risen by +$46.94 million (+213.67%).
- XENE annual SGA is now at all-time high.
Performance
XENE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$18.00 M
+$1.30 M+7.78%
December 31, 2024
Summary
- As of March 10, 2025, XENE quarterly SGA is $18.00 million, with the most recent change of +$1.30 million (+7.78%) on December 31, 2024.
- Over the past year, XENE quarterly SGA has stayed the same.
- XENE quarterly SGA is now -7.20% below its all-time high of $19.40 million, reached on June 30, 2024.
Performance
XENE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.22 B
-$234.33 M-7.86%
December 31, 2024
Summary
- As of March 10, 2025, XENE TTM SGA is -$3.22 billion, with the most recent change of -$234.33 million (-7.86%) on December 31, 2024.
- Over the past year, XENE TTM SGA has dropped by -$3.29 billion (-4769.28%).
- XENE TTM SGA is now -2655.69% below its all-time high of -$116.75 million.
Performance
XENE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
XENE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.0% | 0.0% | -4769.3% |
| 3 y3 years | +213.7% | +165.8% | -10000.0% |
| 5 y5 years | +537.8% | +165.8% | -10000.0% |
XENE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +213.7% | -7.2% | +169.2% | -147.5% | at low |
| 5 y | 5-year | at high | +537.8% | -7.2% | +479.7% | -243.5% | at low |
| alltime | all time | at high | +1190.1% | -7.2% | >+9999.0% | -2655.7% | at low |
Xenon Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $68.90 M(+48.0%) | $18.00 M(+7.8%) | $68.90 M(+8.5%) |
| Sep 2024 | - | $16.71 M(-13.9%) | $63.52 M(+6.5%) |
| Jun 2024 | - | $19.40 M(+31.2%) | $59.62 M(+15.1%) |
| Mar 2024 | - | $14.79 M(+17.2%) | $51.80 M(+11.3%) |
| Dec 2023 | $46.54 M(+41.9%) | $12.62 M(-1.4%) | $46.54 M(+9.7%) |
| Sep 2023 | - | $12.80 M(+10.5%) | $42.42 M(+10.3%) |
| Jun 2023 | - | $11.58 M(+21.5%) | $38.45 M(+8.1%) |
| Mar 2023 | - | $9.54 M(+12.2%) | $35.57 M(+8.4%) |
| Dec 2022 | $32.81 M(+49.4%) | $8.50 M(-3.7%) | $32.81 M(+5.8%) |
| Sep 2022 | - | $8.83 M(+1.4%) | $31.00 M(+14.8%) |
| Jun 2022 | - | $8.71 M(+28.5%) | $27.00 M(+9.6%) |
| Mar 2022 | - | $6.78 M(+1.3%) | $24.63 M(+12.1%) |
| Dec 2021 | $21.97 M(+69.7%) | $6.69 M(+38.4%) | $21.97 M(+19.5%) |
| Sep 2021 | - | $4.83 M(-23.8%) | $18.39 M(+9.7%) |
| Jun 2021 | - | $6.34 M(+54.3%) | $16.76 M(+22.1%) |
| Mar 2021 | - | $4.11 M(+32.3%) | $13.73 M(+6.1%) |
| Dec 2020 | $12.94 M(+19.8%) | $3.11 M(-3.2%) | $12.94 M(-0.5%) |
| Sep 2020 | - | $3.21 M(-3.1%) | $13.01 M(+4.1%) |
| Jun 2020 | - | $3.31 M(-0.3%) | $12.51 M(+8.7%) |
| Mar 2020 | - | $3.32 M(+4.6%) | $11.50 M(+6.5%) |
| Dec 2019 | $10.80 M(+28.5%) | $3.17 M(+17.6%) | $10.80 M(+11.6%) |
| Sep 2019 | - | $2.70 M(+17.0%) | $9.68 M(+8.5%) |
| Jun 2019 | - | $2.31 M(-12.0%) | $8.92 M(+1.5%) |
| Mar 2019 | - | $2.62 M(+27.7%) | $8.79 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $8.41 M(+14.9%) | $2.05 M(+5.9%) | $8.41 M(+4.8%) |
| Sep 2018 | - | $1.94 M(-11.0%) | $8.02 M(+2.5%) |
| Jun 2018 | - | $2.18 M(-2.7%) | $7.83 M(+5.1%) |
| Mar 2018 | - | $2.24 M(+34.0%) | $7.45 M(+1.9%) |
| Dec 2017 | $7.31 M(+7.7%) | $1.67 M(-4.2%) | $7.31 M(+3.2%) |
| Sep 2017 | - | $1.74 M(-3.1%) | $7.08 M(-0.5%) |
| Jun 2017 | - | $1.80 M(-14.3%) | $7.12 M(+1.8%) |
| Mar 2017 | - | $2.10 M(+45.6%) | $7.00 M(+3.0%) |
| Dec 2016 | $6.79 M(-30.6%) | $1.44 M(-18.9%) | $6.79 M(-1.8%) |
| Sep 2016 | - | $1.78 M(+6.1%) | $6.92 M(+7.1%) |
| Jun 2016 | - | $1.68 M(-11.6%) | $6.46 M(+30.2%) |
| Mar 2016 | - | $1.90 M(+20.9%) | $4.96 M(-49.3%) |
| Dec 2015 | $9.79 M(+78.1%) | $1.57 M(+18.6%) | $9.79 M(+1.8%) |
| Sep 2015 | - | $1.32 M(+642.1%) | $9.61 M(+0.1%) |
| Jun 2015 | - | $178.00 K(-97.4%) | $9.60 M(-10.9%) |
| Mar 2015 | - | $6.72 M(+383.5%) | $10.78 M(+96.1%) |
| Dec 2014 | $5.50 M(+2.9%) | $1.39 M(+5.6%) | $5.50 M(+11.5%) |
| Sep 2014 | - | $1.32 M(-2.8%) | $4.93 M(-7.1%) |
| Jun 2014 | - | $1.35 M(-5.7%) | $5.30 M(+34.3%) |
| Mar 2014 | - | $1.44 M(+74.9%) | $3.95 M(+57.1%) |
| Dec 2013 | $5.34 M(-23.8%) | $821.00 K(-51.5%) | $2.51 M(+48.5%) |
| Sep 2013 | - | $1.69 M | $1.69 M |
| Dec 2012 | $7.01 M(+4.1%) | - | - |
| Dec 2011 | $6.73 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual SGA year-on-year change?
- What is Xenon Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly SGA year-on-year change?
- What is Xenon Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM SGA year-on-year change?
What is Xenon Pharmaceuticals annual SGA?
The current annual SGA of XENE is $68.90 M
What is the all time high annual SGA for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual SGA is $68.90 M
What is Xenon Pharmaceuticals annual SGA year-on-year change?
Over the past year, XENE annual SGA has changed by +$22.36 M (+48.05%)
What is Xenon Pharmaceuticals quarterly SGA?
The current quarterly SGA of XENE is $18.00 M
What is the all time high quarterly SGA for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly SGA is $19.40 M
What is Xenon Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, XENE quarterly SGA has changed by $0.00 (0.00%)
What is Xenon Pharmaceuticals TTM SGA?
The current TTM SGA of XENE is -$3.22 B
What is the all time high TTM SGA for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM SGA is -$116.75 M
What is Xenon Pharmaceuticals TTM SGA year-on-year change?
Over the past year, XENE TTM SGA has changed by -$3.29 B (-4769.28%)